Thema
Journal Article
41
Antibodies, Viral
26
SARS-CoV-2
22
Antibodies, Neutralizing
18
Research Support, Non-U.S. Gov't
18
spike protein, SARS-CoV-2
11
Immunoglobulin G
9
Spike Glycoprotein, Coronavirus
9
570
8
Biology
8
COVID-19
7
COVID-19 Vaccines
7
Immunoglobulin M
5
Italy
5
Comparative Study
4
Immunization
4
Parasites
4
seroprevalence
4
Antigens
3
Immune Sera
3
Immunoglobulin A
3
Influenza Vaccines
3
Leishmaniasis
3
Protozoa
3
Viral vaccines
3
antibodies
3
epidemiology
3
neutralization
3
615
2
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
2
Antibodies, Monoclonal
2
Apulia region
2
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
2
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
2
C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms
2
Hemagglutinin Glycoproteins, Influenza Virus
2
IFN-γ
2
Influenza
2
Neutralizing antibodies
2
Review
2
Vaccines
2
Vaccines, Attenuated
2
Vaccines, Inactivated
2
abnormal fetal growth
2
bio
2
che
2
emerging variants
2
gestational diabetes
2
hemagglutinin
2
humoral immunity
2
mehr ...